Profil
David Kelly is currently the Chief Financial Officer at ArraVasc Ltd.
Prior to this, he worked as a Principal at Boston Scientific Corp., Aryzta AG, and Chanelle Pharmaceuticals Manufacturing Ltd.
He also served as the Chief Financial Officer & Treasurer at Cappella, Inc.
Aktive Positionen von David Kelly
| Unternehmen | Position | Beginn |
|---|---|---|
ArraVasc Ltd.
 ArraVasc Ltd. Medical SpecialtiesHealth Technology ArraVasc Ltd. develops novel solutions for the treatment of complex coronary artery disease. The private company is based in Ballybrit, Ireland. The Irish company was founded in 2005 by Antonio Colombo, Ascher Shmulewitz. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von David Kelly
| Unternehmen | Position | Ende |
|---|---|---|
| ARYZTA AG | Corporate Officer/Principal | - |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
Chanelle Pharmaceuticals Manufacturing Ltd.
 Chanelle Pharmaceuticals Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Chanelle Pharmaceuticals Manufacturing Ltd. engages in the development, production, marketing, and distribution of generic animal pharmaceutical products. Its veterinary products include Anthelmintics, Antibiotics, Sedatives, NSAIDs, Cardiovascular, Ectoparasiticides, and Anti-Epileptic drugs. The company was founded on June 14, 1984 and is headquartered in Loughrea, Ireland. | Corporate Officer/Principal | - |
Cappella, Inc.
 Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| ARYZTA AG | Retail Trade |
| Private Unternehmen | 3 |
|---|---|
Cappella, Inc.
Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Health Technology |
Chanelle Pharmaceuticals Manufacturing Ltd.
Chanelle Pharmaceuticals Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Chanelle Pharmaceuticals Manufacturing Ltd. engages in the development, production, marketing, and distribution of generic animal pharmaceutical products. Its veterinary products include Anthelmintics, Antibiotics, Sedatives, NSAIDs, Cardiovascular, Ectoparasiticides, and Anti-Epileptic drugs. The company was founded on June 14, 1984 and is headquartered in Loughrea, Ireland. | Health Technology |
ArraVasc Ltd.
ArraVasc Ltd. Medical SpecialtiesHealth Technology ArraVasc Ltd. develops novel solutions for the treatment of complex coronary artery disease. The private company is based in Ballybrit, Ireland. The Irish company was founded in 2005 by Antonio Colombo, Ascher Shmulewitz. | Health Technology |
